Duncan Barbara Gayle 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Duncan Barbara Gayle
Director
Transactions
- Award
Restricted Stock Units
2023-06-16+33,150→ 33,150 total→ Common Stock (33,150 underlying) - Award
Stock Option (Right to Buy)
2023-06-16+46,750→ 46,750 totalExercise: $4.12Exp: 2033-06-15→ Common Stock (46,750 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- [F3]The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.